Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
biomarker
Biotech
Oculis sees promise in dry eye disease subgroup, plans phase 3
Oculis is advancing its precision medicine approach to dry eye disease, outlining plans to finalize a phase 3 study after seeing signs of efficacy.
Nick Paul Taylor
Jun 10, 2024 7:20am
Alto's 2nd precision psychiatry med improves depression symptoms
Dec 4, 2023 5:00pm
Alnylam's RNAi approach to Alzheimer's reaches biomarker target
Jul 17, 2023 2:21am
New test detects Parkinson's biomarker before movement symptoms
Apr 18, 2023 6:00am
Koneksa links with SSI to advance digital biomarker services
Mar 9, 2023 7:05am
Crown Bioscience, JSR team to acquire IndivuServ unit
Jan 31, 2023 3:10pm
